Haematopoietic growth factors in children with neutropenia.
Lehrnbecher
Thomas
T
Department of Paediatric Haematology and Oncology, University of Frankfurt, Germany. thomas_lehrnbecher@yahoo.com
Welte
Karl
K
D000741:Anemia, Aplastic / Q000150:complications / Q000188:drug therapy; D001424:Bacterial Infections / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy / Q000517:prevention & control*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy; D018579:Patient Selection; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D012189:Retrospective Studies
D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor